Moderna Inc (NASDAQ:MRNA)

147.66
Delayed Data
As of May 27
 +11.86 / +8.73%
Today’s Change
119.01
Today|||52-Week Range
497.49
-41.86%
Year-to-Date
Will This Beaten-Down Stock Bounce Back? 3 Things to Know
May 28 / MotleyFool.com - Paid Partner Content
2 Struggling Stocks That Aren't Likely to Recover Anytime Soon
May 26 / MotleyFool.com - Paid Partner Content
Why Moderna Stock Is Jumping Today
May 27 / MotleyFool.com - Paid Partner Content
Better Buy Ahead of FDA Meetings: Moderna vs. Novavax
May 25 / MotleyFool.com - Paid Partner Content
Knowing This Number Can Save Your Portfolio From Disaster
May 27 / MotleyFool.com - Paid Partner Content
4 Nasdaq 100 Stocks Billionaires Piled Into During the First Quarter
May 25 / MotleyFool.com - Paid Partner Content
Why Novavax Was Tumbling by 12% This Week
May 26 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
May 24 / Zacks.com - Paid Partner Content
Theleme Partners LLP's Top 5 Buys of the 1st Quarter
May 26 / GuruFocus News - Paid Partner Content
Ocugen (OCGN) Covaxin Studies Clinical Hold Lifted by FDA
May 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close135.80
Today’s open137.38
Day’s range136.59 - 148.54
Volume7,590,709
Average volume (3 months)7,370,225
Market cap$58.7B
Data as of 05/27/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1.44%
Earnings growth (next 5 years)-37.83%
Revenue growth (last year)+2,191.90%
P/E ratio--
Price/Sales5.95
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+14.49+5.95%
GILDGilead Sciences+0.33+0.51%
BIIBBiogen+1.98+0.97%
----
Data as of 05/27/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)$4.74
Annual revenue (last year)$18.4B
Annual profit (last year)$12.2B
Net profit margin66.27%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts